VIDEO: Endocrine therapy studies produce ‘significant downstaging’
In this video, Kelly K. Hunt, MD, FACS, FSSO, professor and chair of the department of breast surgical oncology at The University of Texas MD Anderson Cancer Center, discussed presentations in neoadjuvant endocrine therapy at the 38th Annual Miami Breast Cancer Conference.
“Sometimes clinicians don't think about targeted therapies in the hormone receptor positive patients as far as endocrine therapy, and that's a really very exciting area because when we use endocrine therapy in the neoadjuvant setting, we know that we can get some significant downstaging in the patients and make them more likely to be able to have breast conserving surgery as opposed to mastectomy for those who have large tumors,” Hunt told Healio.
Collapse
Healio Interview
Read more about